SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:oru-90325"
 

Search: id:"swepub:oai:DiVA.org:oru-90325" > Pregnancy outcomes ...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Jarrick, Simon,1977-Örebro universitet,Institutionen för medicinska vetenskaper,Department of Pediatrics, Örebro University Hospital, Örebro, Sweden (author)

Pregnancy outcomes in women with immunoglobulin A nephropathy : a nationwide population-based cohort study

  • Article/chapterEnglish2021

Publisher, publication year, extent ...

  • 2021-03-08
  • Springer,2021
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:oru-90325
  • https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-90325URI
  • https://doi.org/10.1007/s40620-021-00979-2DOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:146209268URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Funding Agencies:Research Committee of Örebro County Council  Janssen corporation 
  • BACKGROUND: Immunoglobulin A nephropathy (IgAN) incidence peaks in childbearing age. Data on pregnancy outcomes in women with IgAN are limited.METHODS: We performed a register-based cohort study in a nationwide cohort of women with biopsy-verified IgAN in Sweden, comparing 327 pregnancies in 208 women with biopsy-verified IgAN and 1060 pregnancies in a matched reference population of 622 women without IgAN, with secondary comparisons with sisters to IgAN women. Adverse pregnancy outcomes, identified by way of the Swedish Medical Birth Register, were compared through multivariable logistic regression and presented as adjusted odds ratios (aORs). Main outcome was preterm birth (< 37 weeks). Secondary outcomes were preeclampsia, small for gestational age (SGA), low 5-min Apgar score (< 7), fetal or infant loss, cesarean section, and gestational diabetes.RESULTS: We found that IgAN was associated with an increased risk of preterm birth (13.1% vs 5.6%; aOR = 2.69; 95% confidence interval [CI] = 1.52-4.77), preeclampsia (13.8% vs 4.2%; aOR = 4.29; 95%CI = 2.42-7.62), SGA birth (16.0% vs 11.1%; aOR = 1.84; 95%CI = 1.17-2.88), and cesarean section (23.9% vs 16.2%; aOR = 1.74, 95%CI = 1.14-2.65). Absolute risks were low for intrauterine (0.6%) or neonatal (0%) death and for low 5-min Apgar score (1.5%), and did not differ from the reference population. Sibling comparisons suggested increased risks of preterm birth, preeclampsia, and SGA in IgAN, but not of cesarean section.CONCLUSION: We conclude that although most women with IgAN will have a favorable pregnancy outcome, they are at higher risk of preterm birth, preeclampsia and SGA. Intensified supervision during pregnancy is warranted.

Subject headings and genre

Added entries (persons, corporate bodies, meetings, titles ...)

  • Lundberg, SigridKarolinska Institutet (author)
  • Stephansson, OlofKarolinska Institutet (author)
  • Symreng, AdinaClinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden (author)
  • Bottai, MatteoKarolinska Institutet (author)
  • Höijer, JonasDivision of Biostatisitcs, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (author)
  • Ludvigsson, Jonas F.,1969-Karolinska Institutet(Swepub:oru)jsln (author)
  • Örebro universitetInstitutionen för medicinska vetenskaper (creator_code:org_t)

Related titles

  • In:JN. Journal of Nephrology: Springer34:5, s. 1591-15981121-84281724-6059

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Search outside SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view